The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2013
DOI: 10.1016/j.ijsu.2013.06.485
|View full text |Cite
|
Sign up to set email alerts
|

Does melanotan injections (TAN JAB) cause melanoma? A systemic review of the effects of melanotan injections

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2014
2014
2014
2014

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…There is a lack of research addressing the long term effects of Melanotan I and II despite clinicians reporting concerns around its use relating to increased skin pigmentation, rhabdomyolysis, systemic toxicity with sympathomimetic symptoms, renal dysfunction and reversible encephalopathy syndrome (Javed, Yarrow, & Hemmington Gorse, 2013;Kaski, Stafford, Mehta, Jenkins, & Malhotra, 2013;Nelson et al, 2012). Dysplastic changes in existing nevi, eruptive atypical melanocytic nevi or appearance of new lesions and freckles following melanotan use are common (Burian, 2013;Cardones, Rand, & Richnik, 2009;Cousen et al, 2009;Ferrandiz-Pulido, Fernandez-Figueras, Quer, & Ferrandiz, 2011;Hueso-Gabriel et al, 2012;Javed et al, 2013;Langan, Ramlogan, Jamieson, & Rhodes, 2009;Langan et al, 2010;Ong & Bowling, 2012;Paurobally et al, 2011;Reid, Fitzgerald, Fabre, & Kirby, 2013;Sivyer, 2012;Thestrup-Pedersen & Sondergaard, 2010).…”
Section: E-mail Address: Mcvanhout@witiementioning
confidence: 99%
See 1 more Smart Citation
“…There is a lack of research addressing the long term effects of Melanotan I and II despite clinicians reporting concerns around its use relating to increased skin pigmentation, rhabdomyolysis, systemic toxicity with sympathomimetic symptoms, renal dysfunction and reversible encephalopathy syndrome (Javed, Yarrow, & Hemmington Gorse, 2013;Kaski, Stafford, Mehta, Jenkins, & Malhotra, 2013;Nelson et al, 2012). Dysplastic changes in existing nevi, eruptive atypical melanocytic nevi or appearance of new lesions and freckles following melanotan use are common (Burian, 2013;Cardones, Rand, & Richnik, 2009;Cousen et al, 2009;Ferrandiz-Pulido, Fernandez-Figueras, Quer, & Ferrandiz, 2011;Hueso-Gabriel et al, 2012;Javed et al, 2013;Langan, Ramlogan, Jamieson, & Rhodes, 2009;Langan et al, 2010;Ong & Bowling, 2012;Paurobally et al, 2011;Reid, Fitzgerald, Fabre, & Kirby, 2013;Sivyer, 2012;Thestrup-Pedersen & Sondergaard, 2010).…”
Section: E-mail Address: Mcvanhout@witiementioning
confidence: 99%
“…Dysplastic changes in existing nevi, eruptive atypical melanocytic nevi or appearance of new lesions and freckles following melanotan use are common (Burian, 2013;Cardones, Rand, & Richnik, 2009;Cousen et al, 2009;Ferrandiz-Pulido, Fernandez-Figueras, Quer, & Ferrandiz, 2011;Hueso-Gabriel et al, 2012;Javed et al, 2013;Langan, Ramlogan, Jamieson, & Rhodes, 2009;Langan et al, 2010;Ong & Bowling, 2012;Paurobally et al, 2011;Reid, Fitzgerald, Fabre, & Kirby, 2013;Sivyer, 2012;Thestrup-Pedersen & Sondergaard, 2010). Cases of malignant melanomas have also been reported (Ellis, Kirkham, & Seukeran, 2009;Paurobally et al, 2011Paurobally et al, , 2013.…”
Section: E-mail Address: Mcvanhout@witiementioning
confidence: 99%